Pediatric Radiation Therapy Registry
Part of paid clinical trials in Washington D.C., District of Columbia.
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Study ID
- NCT07129317
- Status
- Recruiting
Conditions
- Pediatric Brain Tumors
- Sarcoma
Eligibility Criteria
- Sex
- ALL
- Age
- 0 Years - 26 Years
- Healthy Volunteers
- Not accepted
Study Details
The Johns Hopkins Pediatric Radiation Oncology Program is creating a registry that will capture the full 3D radiation dosimetry delivered to its pediatric patients to manage the quality of care provided, as well as to examine the long-term outcomes and toxicity of each patient. The registry will capture baseline clinical data, disease, toxicity, and quality of life outcomes. The goal is to include all pediatric patients undergoing proton therapy and photon therapy to enable future comparisons of treatment outcomes.
Key Dates
- Start date
- Oct 31, 2025
- Status verified
- Nov 2025
- Primary completion
- Sep 30, 2035
- Completion
- Sep 30, 2040
Study Design
- Enrollment
- 5,000 participants (estimated)
Arms
- Arm: Pediatric brain tumorsPediatric patients diagnosed with brain tumors requiring treatment with either proton or photon radiation therapy.
- Arm: Pediatric sarcomasPediatric patients diagnosed with bone or soft tissue sarcomas requiring treatment with either proton or photon radiation therapy.
- Arm: Non-brain-tumor and non-sarcoma
Primary Outcome Measure
Overall Survival [ Time Frame: Approximately 10 years ]
Central Contacts
- Ethan Arnone, BS2029192533
- Betsy Sawdy, MSN2029192551
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Sibley Memorial Hospital | Washington D.C. | District of Columbia | 20016 | Betsy Sawdy, MSN Sahaja Acharya, MD (PRINCIPAL_INVESTIGATOR) |
| Johns Hopkins Hospital | Baltimore | Maryland | 21287 | Betsy Sawdy, MSN Sahaja Acharya, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Washington D.C., DC
Related Studies
- Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological StudiesRecruiting · National Cancer Institute (NCI) · Washington D.C., District of Columbia
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...PHASE1 · Recruiting · National Cancer Institute (NCI) · Bethesda, Maryland
- LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic OncologyPHASE4 · Enrolling By Invitation · Massachusetts General Hospital · Los Angeles, California